GigaGen works on recombinant polyclonal antibody against Covid-19

31 March 2020 (Last Updated March 31st, 2020 14:09)

GigaGen is working on a recombinant polyclonal antibody, recombinant anti-coronavirus 19 hyperimmune gammaglobulin (rCIG), as a Covid-19 treatment.

The therapy reproduces whole antibody repertoires of recovered patients, including antibodies that block further replication of the novel coronavirus.

GigaGen will formulate the antibody for intravenous administration to deliver passive immunity.

Read the full article here